All Stories

  1. British Thyroid Association Survey of Graves' Disease Management in the UK
  2. Thyroid Research celebrates its 15th year of publication achieving its first Journal impact factor
  3. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement
  4. Gene expression signature predicts rate of type 1 diabetes progression
  5. Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
  6. Continuous glucose monitoring for diabetes: potential pitfalls for the general physician
  7. Patient‐led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight
  8. TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis
  9. Association of Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies with Thyroid Function in Pregnancy: An Individual Participant Data Meta-Analysis
  10. INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
  11. Postradioiodine Graves' management: The PRAGMA study
  12. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
  13. Mendelian randomization to investigate the link between TSH and thyroid cancer
  14. Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspective
  15. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis
  16. Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study
  17. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis
  18. Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide
  19. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
  20. The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review
  21. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
  22. Does a simple web-based intervention facilitate the articulation of patients’ unvoiced agenda for a consultation with their diabetologists? A qualitative study
  23. Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy
  24. Effect of perchlorate and thiocyanate exposure on thyroid function of pregnant women from South-West England: a cohort study
  25. Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B
  26. Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis
  27. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism
  28. Thyroid Physiology and Thyroid Diseases in Pregnancy
  29. Raising awareness of Graves' orbitopathy with early warning cards
  30. Interpretation of thyroid scintigraphy is inconsistent among endocrinologists
  31. Bony changes in primary hyperparathyroidism
  32. Subclinical hypothyroidism: Should we treat?
  33. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit
  34. A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study
  35. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration
  36. Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive
  37. Thyroid Physiology and Thyroid Diseases in Pregnancy
  38. Iodine deficiency amongst pregnant women in South-West England
  39. Exploring the motivations of patients with type 2 diabetes to participate in clinical trials: a qualitative analysis
  40. A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline
  41. Effectiveness of interventions to reduce ordering of thyroid function tests: a systematic review
  42. Iodine supplementation in pregnancy - is it time?
  43. Thyroid research: stepping forward
  44. Maternal thyroid function in pregnant women with a breech presentation in late gestation
  45. SOS1frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B
  46. Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters
  47. Investigating hyperkalaemia in adults
  48. Correction: Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
  49. Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
  50. The authors' reply: Too early to dismiss the block & replace regime for Graves' disease
  51. Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways
  52. Diagnosis of Graves' Orbitopathy (DiaGO): Results of a Pilot Study to Assess the Utility of an Office Tool for Practicing Endocrinologists
  53. Recurrent phaeochromocytoma along the laparoscopic portal sites
  54. Endocrinology
  55. An international survey of screening and management of hypothyroidism during pregnancy in Latin America
  56. TSH Levels and Risk of Miscarriage in Women on Long-Term Levothyroxine: A Community-Based Study
  57. Diagnosis and management of thyrotoxicosis
  58. Impact of Month of Birth on the Development of Autoimmune Thyroid Disease in the United Kingdom and Europe
  59. Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves’ disease: a retrospective observational study
  60. Abklärung einer Hypokaliämie
  61. RET genetic screening in patients with multiple endocrine neoplasia type 2 and medullary thyroid carcinoma: experience of the Exeter Molecular Genetics Laboratory
  62. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease
  63. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children
  64. Screening and management of hypothyroidism in pregnancy: Results of an Asian survey
  65. Management of hyperthyroidism during pregnancy in Asia
  66. A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists
  67. Five-Year Follow-Up for Women With Subclinical Hypothyroidism in Pregnancy
  68. Preoperative Endocrine Function and Fluid Electrolyte Balance
  69. Investigating hypokalaemia
  70. A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)
  71. Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review
  72. Management of patients in a combined thyroid eye clinic in secondary care
  73. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
  74. Should subclinical hypothyroidism diagnosed during pregnancy be treated with long-termL-thyroxine?
  75. A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function
  76. Management of hypothyroidism in pregnancy: we must do better
  77. New guidelines for the management of hypothyroidism
  78. Amiodarone‐induced thyrotoxicosis, an overview of UK management
  79. Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
  80. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme
  81. Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?
  82. Phaeochromocytoma
  83. Side Effects of Anti-Thyroid Drugs and Their Impact on the Choice of Treatment for Thyrotoxicosis in Pregnancy
  84. Management of Hyperthyroidism in Pregnancy: Results of a Survey among Members of the European Thyroid Association
  85. 2012 European Thyroid Association Guidelines for the Management of Familial and Persistent Sporadic Non-Autoimmune Hyperthyroidism Caused by Thyroid-Stimulating Hormone Receptor Germline Mutations
  86. Treatment and screening of hypothyroidism in pregnancy: results of a European survey
  87. Orbital decompression for Graves’ orbitopathy in England
  88. Treatment for primary hypothyroidism: current approaches and future possibilities
  89. Spontaneously resolving Addison's disease
  90. Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene
  91. A woman with episodic headaches, sweating, and palpitations
  92. Fetal Thyroid Hormone Level at Birth Is Associated with Fetal Growth
  93. Immunomodulation of New-Onset Addison Disease Using B Lymphocyte Depletion Therapy: Interim Analysis
  94. Iodine status of UK schoolgirls: a cross-sectional survey
  95. A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement
  96. Quality of life in thyroid eye disease: impact of quality of care
  97. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy
  98. Addison’s Disease Due to Bilateral Adrenal Infarction in a Patient with Myelodysplastic Syndrome
  99. Thyroid and Pregnancy
  100. Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy
  101. Thyroid hormone resistance in identical twins
  102. An elderly woman with recurrent episodes of confusion
  103. Addison Disease in Adults: Diagnosis and Management
  104. Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease
  105. Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy
  106. Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy
  107. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey
  108. Addison’s disease
  109. Addison's disease
  110. Addison's disease
  111. Common Variation in theDIO2Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients
  112. Germline mutations in the CDKN1B gene encoding p27Kip1 are a rare cause of multiple endocrine neoplasia type 1
  113. Cigarette Smoking during Pregnancy Is Associated with Alterations in Maternal and Fetal Thyroid Function
  114. Pituitary apoplexy within a macroprolactinoma
  115. A Common Variation in Deiodinase 1 GeneDIO1Is Associated with the Relative Levels of Free Thyroxine and Triiodothyronine
  116. Management of hypothyroidism in adults
  117. R. Lorini, M. Maghnie, G. D’Annunzio, S. Loche, M. O. Savage (eds) Congenital endocrinopathies: new insights into endocrine diseases and diabetes
  118. Wide variation in surgical outcomes for acromegaly in the UK
  119. Carpopedal spasm in an elderly man: an unusual presentation of coeliac disease
  120. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists
  121. The impact of thyroid eye disease upon patients’ wellbeing: a qualitative analysis
  122. Analysis of gross deletions in theMEN1gene in patients with multiple endocrine neoplasia type 1
  123. Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding?
  124. Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype
  125. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes
  126. Phenotypic Multiple Endocrine Neoplasia Type 2B, Without Endocrinopathy or RET Gene Mutation: Implications for Management
  127. What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves’ disease
  128. Analysis of Peripheral Blood T-Cell Subsets in Active Thyroid-Associated Ophthalmopathy: Absence of Effect of Octreotide-LAR on T-Cell Subsets in Patients with Thyroid-Associated Ophthalmopathy
  129. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing
  130. Double-Blind, Placebo-Controlled Trial of Octreotide Long-Acting Repeatable (LAR) in Thyroid-Associated Ophthalmopathy
  131. Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases
  132. Severe hypothyroidism after thalidomide treatment
  133. CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy
  134. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation
  135. Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na+-K+ leak in a xerocytic form
  136. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies
  137. CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism
  138. Socio-economic deprivation and diabetic foot ulcers: no strong association
  139. The Genetics of Autoimmune Thyroid Disease
  140. Screening for thyroid disease in pregnancy: an audit
  141. A race to the lab
  142. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies
  143. Evidence for a Graves’ Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population1
  144. Evidence for a Graves' Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population
  145. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
  146. Evidence for a New Graves Disease Susceptibility Locus at Chromosome 18q21
  147. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
  148. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison’s Disease1
  149. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison's Disease
  150. Further Evidence for a Susceptibility Locus on Chromosome 20q13.11 in Families with Dominant Transmission of Graves Disease
  151. Concurrence of Pendred Syndrome, Autoimmune Thyroiditis, and Simple Goiter in One Family
  152. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy
  153. Concurrence of Pendred Syndrome, Autoimmune Thyroiditis, and Simple Goiter in One Family
  154. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
  155. A Common and Recurrent 13-bp Deletion in the Autoimmune Regulator Gene in British Kindreds with Autoimmune Polyendocrinopathy Type 1
  156. Cerebral Venous Sinus Thrombosis: A Late Sequel of Invasive Fibrous Thyroiditis
  157. Corticosteroid therapy in Riedel's thyroiditis.
  158. Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing's syndrome.
  159. Hypothalamic adipsic syndrome: diagnosis and management